<DOC>
	<DOCNO>NCT01017835</DOCNO>
	<brief_summary>The purpose study determine whether combined therapy simvastatin hypotensive drug ( ACEI ARB ) may decrease blood pressure . Moreover , would like assess influence isolate hypertension endothelial injury , development atherosclerosis .</brief_summary>
	<brief_title>Simvastatin Patients With Isolated Arterial Hypertension</brief_title>
	<detailed_description>Hypertension one important predictor cardiovascular disease ( CVD ) . Due fact hypertension frequently coexist hypercholesterolemia diabetes increase risk CVDs development , advisable use optimal combine therapy ( hypotensive + hypolipidemic + hypoglycemic ) group patient . Statins effective widely use drug treatment hypercholesterolemia . According available experimental clinical data may decrease blood pressure ( BP ) normotensive hypertensive patient . However , still difficult determine degree reduction blood pressure cardiovascular risk due hypotensive hypolipidemic/pleiotropic effect statin .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>isolate hypertension ( I II class accord ESH guideline 2009 ) ischemic heart disease , prior percutaneous coronary intervention ( PCI ) , prior coronary artery bypass grafting ( CABG ) , heart failure , diabetes , hyperlipidemia , active smoker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>statin</keyword>
	<keyword>isolated hypertension</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>lipid profile</keyword>
</DOC>